Evidence map›Paper›PMID 39263353›Full record

ArticleJournal of pharmaceutical analysis2024

Terpene extract from the stem of

Zewen Chu, Miao Zhu, Yuanyuan Luo, Yaqi Hu, Xinyi Feng, Jiacheng Shen, Haibo Wang, Masataka Sunagawa, Yanqing Liu

Abstract read
In one paragraph

Article in Journal of pharmaceutical analysis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zewen ChuInstitute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, Jiangsu, 225001, China.
Miao ZhuInstitute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, Jiangsu, 225001, China.
Yuanyuan LuoInstitute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, Jiangsu, 225001, China.
Yaqi HuInstitute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, Jiangsu, 225001, China.
Xinyi FengInstitute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, Jiangsu, 225001, China.
Jiacheng ShenInstitute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, Jiangsu, 225001, China.
Haibo WangInstitute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, Jiangsu, 225001, China.
Masataka SunagawaDepartment of Physiology, School of Medicine, Showa University, Tokyo, 142-8555, Japan.
Yanqing LiuInstitute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, Jiangsu, 225001, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adjuvant chemoradiotherapy, molecular targeted therapy, and immunotherapy are frequently employed to extend the survival of patients with advanced gastric cancer (GC). However, most of these treatments have toxic side effects, drug resistance, and limited improvements in survival and quality of life. Therefore, it is crucial to discover and develop new medications targeting GC that are highly effective and have minimal toxicity. In previous studies, the total terpene extract from the stem of

Indexed as

Actin skeleton remodellingAlpha actinin-4Gastric cancerPolypyrimidine tract binding protein 1Traditional Chinese medicine

Identifiers

PMID39263353
PMCPMC11388708

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.